skingenix
Original Research Articles in Chronic Wounds, Ulcers and Scars

1.

(2003) BS Atiyeh, CA Al-Amm, KA EI-Musa. The Effect of Moist and Moist Exposed Dressings on Healing and Barrier Function Restoration of Partial Thickness Wounds. European Journal of Plastic Surgery 2003; 26(2): 5-11.

2.

(2003) BS Atiyeh, El-Musa KA, Dham R. Scar Quality and Physiologic Barrier Function Restoration after Moist and Moist-Exposed Dressings of Partial-Thickness Wounds. Dermatol Surg 2003 Jan; 29(1):14-20.

3.

(2002) Bishara S Atiyeh, John Ioannovich, Christian A Al-Amm, et al. Improving Scar Quality: A Prospective Clinical Study. Anesthetic Plastic Surgery 2002; 26: 470-476.

4.

(2002) Ait-Aissa M. Advances in the Use of MEBO (A New Approach in the Method of Applications). Annal of Burns and Fire Disasters 2002; XV (1): 1-4.

5.

(2002) BS Atiyeh, J Ioannovich. Efficacy of Moist Exposed Burn Ointment in the Management of Cutaneous Wounds and Ulcers: A Multicenter Pilot Study. Ann Plast Surg. Lebanon 2002; 48(2):226-267.

6.

(2000) Ali Al-Numairy, Clinical Use of MEBO in Wounds Management in U.A.E. International Journal of Cosmetic Surgery and Anesthetic Dermatology 2000; 2(1): 27-33.

 
Copyright © 2009-2010 SKINGENIXWEB.COM. All Rights Reserved
The Skingenix, Inc. website has been designed for the audience worldwide. This website contains information about products which may or may not be available in different countries. In addition, the official approval or market clearance for indications of use may also differ per each country. Please consult individual country sites for approved uses and any applicable restrictions.The research data disclosed in this website is wholly for the purpose of scientific information exchange and is not intended for marketing or promotional uses.

Please note that Skingenix's drug product MEBO® Wound Ointment has not been approved by the Food and Drug Administration for any indication of use in the United States. It is currently under the status of Investigational New Drug (Phase II) for patients with burn injuries, venous stasis ulcers and diabetic foot ulcers.